{"nct_id":"NCT06328777","title":"RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis","status":"RECRUITING","status_verified_date":"2025-09","start_date":"2024-07-02","start_date_type":"ACTUAL","primary_completion_date":"2029-07","primary_completion_date_type":"ESTIMATED","completion_date":"2029-07","completion_date_type":"ESTIMATED","phases":["PHASE1","PHASE2"],"tickers":["CABA"]}